Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation

Bridging integrator-1 (BIN1) gene is associated with an increased risk to develop Alzheimer’s disease, a tauopathy characterized by intra-neuronal accumulation of phosphorylated Tau protein as paired helical filaments. Direct interaction of BIN1 and Tau proteins was demonstrated to be mediated through BIN1 SH3 C-terminal domain and Tau (210–240) peptide within Tau proline-rich domain. We previously showed that BIN1 SH3 interaction with Tau is decreased by phosphorylation within Tau proline-rich domain, of at least T231. In addition, the BIN1/Tau interaction is characterized by a dynamic equilibrium between a closed and open conformations of BIN1 isoform 1, involving an intramolecular interaction with its C-terminal BIN1 SH3 domain. However, the role of the BIN1/Tau interaction, and its potential dysregulation in Alzheimer’s disease, is not yet fully understood. Here we showed that within Tau (210–240) peptide, among the two proline-rich motifs potentially recognized by SH3 domains, only motif P216TPPTR221 is bound by BIN1 SH3. A structural model of the complex between BIN1 SH3 and Tau peptide (213–229), based on nuclear magnetic resonance spectroscopy data, revealed the molecular detail of the interaction. P216 and P219 within the proline-rich motif were in direct contact with the aromatic F588 and W562 of the BIN1 SH3 domain. The contact surface is extended through electrostatic interactions between the positively charged R221 and K224 residues of Tau peptide and those negatively charged of BIN1 SH3, corresponding to E556 and E557. We next investigated the impact of multiple Tau phosphorylations within Tau (210–240) on its interaction with BIN1 isoform 1. Tau (210–240) phosphorylated at four different sites (T212, T217, T231, and S235), contrary to unphosphorylated Tau, was unable to compete with the intramolecular interaction of BIN1 SH3 domain with its CLAP domain. In accordance, the affinity of BIN1 SH3 for phosphorylated Tau (210–240) peptide was reduced, with a five-fold increase in the dissociation constant, from a Kd of 44 to 256 μM. This study highlights the complexity of the regulation of BIN1 isoform 1 with Tau. As abnormal phosphorylation of Tau is linked to the pathology development, this regulation by phosphorylation might have important functional consequences.

[1]  M. Pinard.  Structural determinants , 2020, Nationalist Movements Explained.

[2]  A. Teleman,et al.  Bin1 directly remodels actin dynamics through its BAR domain , 2017, EMBO reports.

[3]  J. Lambert,et al.  Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins – role of the SH3 domain , 2017, The FEBS journal.

[4]  Florent Ubelmann,et al.  Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid , 2017, EMBO reports.

[5]  P. Verstreken,et al.  Loss of Bin1 Promotes the Propagation of Tau Pathology. , 2016, Cell reports.

[6]  P. Permi,et al.  Structural Basis of the High Affinity Interaction between the Alphavirus Nonstructural Protein-3 (nsP3) and the SH3 Domain of Amphiphysin-2* , 2016, The Journal of Biological Chemistry.

[7]  H. Soininen,et al.  Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.

[8]  G C P van Zundert,et al.  The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.

[9]  J. Gunawardena,et al.  Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase* , 2016, The Journal of Biological Chemistry.

[10]  I. Landrieu,et al.  Proline Conformation in a Functional Tau Fragment. , 2016, Journal of molecular biology.

[11]  J. Lambert,et al.  Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain , 2015, Acta neuropathologica communications.

[12]  M. Blackledge,et al.  Structural Impact of Tau Phosphorylation at Threonine 231. , 2015, Structure.

[13]  K. Ishiguro,et al.  Physiological and pathological phosphorylation of tau by Cdk5 , 2014, Front. Mol. Neurosci..

[14]  J. Laporte,et al.  Amphiphysin 2 (BIN1) in physiology and diseases , 2014, Journal of Molecular Medicine.

[15]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[16]  M. Owen,et al.  Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.

[17]  I. Landrieu,et al.  Towards understanding the phosphorylation code of tau. , 2012, Biochemical Society transactions.

[18]  I. Landrieu,et al.  Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline‐rich region of the disordered Tau protein , 2012, Proteins.

[19]  T. Sixma,et al.  Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases. , 2011, Journal of structural biology.

[20]  P. Bosco,et al.  APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.

[21]  I. Landrieu,et al.  Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E , 2010, The Journal of Biological Chemistry.

[22]  L. Buée,et al.  NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. , 2010, Biochemical Society transactions.

[23]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[24]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[25]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[26]  P. Camilli,et al.  The BAR Domain Superfamily: Membrane-Molding Macromolecules , 2009, Cell.

[27]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[28]  Thomas Szyperski,et al.  A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. , 2005, Journal of molecular biology.

[29]  L. Buée,et al.  Regulation of Pin1 peptidyl‐prolyl cis/trans isomerase activity by its WW binding module on a multi‐phosphorylated peptide of Tau protein , 2005, FEBS letters.

[30]  Wayne Boucher,et al.  The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.

[31]  L. Buée,et al.  The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. , 2004, Biochemistry.

[32]  C. Dominguez,et al.  HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.

[33]  J. Cho,et al.  Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. , 2003, The Journal of biological chemistry.

[34]  Julie D. Forman-Kay,et al.  Sequential assignment of proline-rich regions in proteins: Application to modular binding domain complexes , 2000, Journal of biomolecular NMR.

[35]  Pietro De Camilli,et al.  Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis , 1999, Nature Cell Biology.

[36]  E. Mandelkow,et al.  Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. , 1998, European journal of biochemistry.

[37]  D. S. Garrett,et al.  Solution structure of the 30 kDa N-terminal domain of enzyme I of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system by multidimensional NMR. , 1997, Biochemistry.

[38]  P. De Camilli,et al.  A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Grzesiek,et al.  Sequential backbone assignment of isotopically enriched proteins in D2O by deuterium-decoupled HA(CA)N and HA(CACO)N , 1995, Journal of biomolecular NMR.

[40]  Wendell A. Lim,et al.  Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains , 1995, Nature.

[41]  S. Schreiber,et al.  Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.

[42]  P. Cohen,et al.  Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.

[43]  E. Mandelkow,et al.  Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5 , 1993, FEBS letters.

[44]  K. Imahori,et al.  Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .

[45]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[46]  G. Drewes,et al.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.

[47]  M. Murphy,et al.  Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology. , 2014, Journal of Alzheimer's disease : JAD.

[48]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[49]  P. Afonine,et al.  research papers Acta Crystallographica Section D Biological , 2003 .

[50]  J. Endicott,et al.  Methods for preparation of proteins and protein complexes that regulate the eukaryotic cell cycle for structural studies. , 2005, Methods in molecular biology.

[51]  F. García-Sierra,et al.  Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[52]  K. Imahori,et al.  Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. , 1993, FEBS letters.

[53]  W. R. Gowers,et al.  Physiological and pathological , 1876 .